Searched for
DOMESTIC DEMAND FOR PHARMACEUTICALS
Pharma sector revenue to grow 11-13 pc in FY27 on strong exports, domestic demand: CrisilIndia's pharmaceutical sector is projected to grow at 11-13 percent this fiscal year due to export increases. The domestic market is also e...- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Reforms improved India’s competitiveness, strengthened resilience: CII’s R MukundanReforms in taxation and digital infrastructure have boosted India's economic competitiveness. GST and the JAM trinity integrated millions i...
- For investors who know and accept that bears can roam the street longer: 5 mid-cap stocks with upside potential of up to 29%It is when the market displays the kind of sentiment it is doing now that most investors develop a strong desire to just get out. That’s qu...
- MFs raise healthcare bets for 4th straight month to 71-month high. Should investors follow?Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...
- Valmiki Leela Capital eyes Rs 3,000 crore IPO pipeline over 18 monthsValmiki Leela Capital has built a ₹3,000 crore IPO pipeline for the next 12-18 months across renewable energy, power, pharmaceuticals, pack...
- India’s semiconductor push will need a new approach to water management: CN WaterIndia’s semiconductor push is creating a new demand for smarter, more reliable water infrastructure. CN Water’s Shoeb Kurawadwala on locali...
- $4 billion CIO Nimesh Chandan spots 4 bullish signals for Indian stocks. What changed?India’s stock market is poised for a broader recovery as four core cycles—macroeconomics, corporate earnings, credit growth, and market sen...
- Business outlook 2027: 7 growth opportunities Indian CXOs should watchIndia is entering 2027 with growth opportunities spread across manufacturing, technology, exports, infrastructure, and emerging consumer ma...
- India's exports under free trade pacts grew faster than imports in April-July: Piyush GoyalExports under free trade agreements are now growing faster than imports. Outbound shipments to FTA partner countries expanded by 23.9 perce...
- Beyond Los Angeles and Rotterdam: Can Durban, Rio de Janeiro drive India’s next export boom?The South-South trade has crossed $7 trillion, opening new opportunities for Indian exporters across Africa, ASEAN, the Gulf, and Latin Ame...
- Centre may provide 100% funding support for medical testing equipment, says Piyush GoyalThe government will fully fund the acquisition of advanced medical testing equipment. Domestic firms are encouraged to seek technology part...
- How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe Indian market was under pressure on Thursday, particularly at the index level. Rising crude-oil prices are an obvious concern, but dome...
- Quant Mutual Fund turns cautious on manufacturing, bets on ‘neglected’ IT ServicesQuant Mutual Fund is pivoting away from manufacturing due to rising cost pressures and supply chain issues. Instead, it's channeling invest...
- India’s growth beat suggests economy on cusp of investment boomIndia's economy grew at a brisk 7.8% pace in the recent quarter. Manufacturing, construction, and services sectors drove this strong econom...
- Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targetsElara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its...
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- India Inc’s revenue growth to moderate to 13-15% in Q2 FY27; margins under pressure: ICRAIndia Inc’s revenue growth is expected to moderate to 13-15% in Q2 FY27 from 21.3% in Q1, ICRA said. Higher input costs could squeeze margi...
- Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
Load More
